MedTrace Logo

Cocaine-Metyrapone Interaction Study - 1

NCT00033098 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2017-01-11

No results posted yet for this study

Summary

The purpose of this study is to examine the safety of two consecutive days of metyrapone (MRP) in subjects who may use cocaine concurrently.

Conditions

  • Cocaine-Related Disorders
  • Infusions, Intravenous

Interventions

DRUG

Metyrapone

Sponsors & Collaborators

  • Cincinnati VA Medical Center

    collaborator OTHER_GOV

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Theresa Winhusen, Ph.D. · Cincinnati VA Medical Center

Study Design

Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-11-30
Completion
2002-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00033098 on ClinicalTrials.gov